Westerkirk Capital Inc. Merck & Co., Inc. Transaction History
Westerkirk Capital Inc.
- $875 Billion
- Q3 2025
A detailed history of Westerkirk Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Westerkirk Capital Inc. holds 47,500 shares of MRK stock, worth $4.41 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
47,500
Previous 33,400
42.22%
Holding current value
$4.41 Million
Previous $2.64 Billion
50.79%
% of portfolio
0.46%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,878Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...